Olmesartan is a medication used in the management of hypertension. It is in the angiotensin receptor blocking (ARB) class of drugs. Olmesartan, like other ARBs, can be used as monotherapy for hypertension in the absence of comorbidities such as chronic kidney disease, cerebrovascular events, heart failure, diabetes, and ischemic heart disease. ARBs have been a recommendation to help lower microalbuminuria in patients with diabetes mellitus and can also lower cardiovascular events and mortality in ischemic heart disease in clinical practice. This activity reviews the indications, mechanism, pharmacokinetics, adverse drug reactions, toxicity, warning, precautions, and contraindications for olmesartan as a valuable agent in managing patients suffering from hypertension.

**Objectives:**
- Identify the mechanism of action of olmesartan.
- Describe the potential adverse effects of olmesartan.
- Summarize the appropriate monitoring for patients taking olmesartan.
- Review how improving care coordination and communication of the team to avoid giving olmesartan in instances of contradiction can ensure the best hypertensive treatment for the patient.